It is essential for researchers to keep abreast of the work being done by colleagues in a variety of disciplines. To facilitate this, the UCLA-CDU CFAR and the UCLA AIDS Institute sponsors a bi-monthly conference featuring presentations made by researchers working in both basic and translational sciences, clinical therapeutics and biomedical prevention. The topics covered include, among many others, host-virus interactions, novel therapeutics, vaccines, stem-cell research, aging, and viral pathogenesis. The Bi-monthly Multidisciplinary Virology Seminar Series is an in-person meeting from 9:00am to 10:00am in the Biomedical Science Research Building (BSRB) 154 every other Tuesday. A light breakfast will be available during the meeting.
For more information regarding the Multidisciplinary Virology Seminar Series and/or to be added to the listserv for these meetings, please contact Rina Lee-Cha.
We’re excited to welcome you back to our Virology Seminar Series, and we’ve got an exciting lineup ahead this season. Whether you’re a long-time attendee or joining us for the first time, we can’t wait to dive back into the latest breakthroughs and discussions in the field of virology.
Date ROOM Presenter 1 Title Presenter 2 Title
9/10/2024 BSRB 154 Arjit Vijey Jeyachandran “Mpox antiviral development and mouse model” Jian Zhang “Modeling HSPC based anti-HIV-1 gene therapy in NHP”
9/24/2024 BSRB 154 Xiaoyu Liu “Molecular Sociology of Cellular Condensates Enabling Reovirus Assembly and Replication” Pablo Alvarez “Unraveling alphavirus neuroinvasion: Molecular insights from a stem cell derived blood brain barrier model”
10/8/2024 BSRB 154 William Mu “Rapamycin treatment improve anti-HIV CAR T cell functions”
10/22/2024 BSRB 154 Justin Meyer, UCSD; Sponsoring faculty: Jamie Lloyd-Smith “Unfolding Evolution: How Destabilizing Mutations Enable Viruses to Adapt to New Receptors”
11/19/2024 BSRB 154 Zheng Cao "Glycolysis Responsive Nanocapsules for Inflammation-site Targeting" Margaret Wang "Engineering enhanced anti-HIV CAR T-cells using CRISPR/Cas9."
12/3/2024 BSRB 154 Bala Arumugam “Targeting HIV-1infection with bNAb-based mono-specific and bi-specific Chimeric Antigen Receptor” Shallu Tomer "Development of an Advanced Glia-Immune Humanized Mouse Model for Investigating HIV-CNS Infection and Neuroinflammation"
12/17/2024 NO MEETING
12/31/2024 NO MEETING
1/14/2025 CANCELLED
1/28/2025 CANCELLED
2/11/2025 BSRB 154 Wenting Chen "Enhanced Delivery of Broadly Neutralizing Antibodies for Targeting CNS Infections." Jeff Harding "Effects of cannabis on immune aging"
2/25/2025 BSRB 154 Chris Hofmann "T-Cell Receptor Gene Therapy for Human Papillomavirus" Nandita Kedia "HSCs-derived CAR-M for Alzheimer’s disease"
3/11/2025 BSRB 154 Shipra Shirma "The role of phosphorylation in regulating virus-host protein complexes" Brian Nguyen "Development of antiviral oligonucleotides
against SARS-CoV-2"
3/25/2025 BSRB 154 Yennifer Delgado “Phosphorylation as a driver of functional diversity: a look at SARS-CoV-2 Membrane protein." Ayub Ali "Engineering bispecific CAR targeting HCMV and HIV-1"
4/8/2025 BSRB 154 Javier Ibarrondo “Anti-HIV Chimeric Antibodies" Xiaoying Cai "Structural Heterogeneity of the Rabies Virus Virion"
4/22/2025 BSRB 154 Declan Winters “Host-Driven Phosphorylation of Viral Proteins as a Regulatory Mechanism during Alphavirus Infection“ Lenka Milojevic
5/6/2025 BSRB 154 Erin Kim Izra Abbaali
5/20/2025 BSRB 154 Christopher Luthers TBD
6/3/2025 BSRB 154 Eva Segura Gensler Kevyn Hart
6/17/2025 BSRB 154 Martin Ruvalcaba TBD